Search Within

Martin Stuart Tallman

Formats
  1. Journal Article (320)
  2. Meeting Abstract (278)
  3. Review (19)
  4. Editorial (9)
  5. Book Section (8)
  6. Research Letter (8)
  7. Guidelines (6)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (649)
  2. Center for Hematologic Malignancies (649)
  3. Department of Medicine (649)
  4. Hematologic Malignancies, Division of (649)
  5. GSK Faculty (164)
  6. Executive Committee, Center for Hematologic Malignancies (156)

More Groups

People
  1. Ross Levine (131)
  2. Eytan Stein (114)
  3. Jae Park (79)
  4. Omar Abdel-Wahab (68)
  5. Sean Devlin (65)
  6. Dan Douer (50)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (10)
  4. 2022 (26)
  5. 2021 (45)
  6. 2020 (51)

More Years

Publications
  1. Blood (272)
  2. Journal of Clinical Oncology (41)
  3. Leukemia Research (27)
  4. Blood Advances (26)
  5. Leukemia and Lymphoma (26)
  6. Haematologica (24)

More Publications

Publishers
  1. American Society of Hematology (298)
  2. Elsevier Inc. (43)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (38)
  5. Taylor & Francis Group (28)
  6. Elsevier Ltd (27)

More Publishers

Results (649)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risks for hospitalization and death among patients with blood disorders from the ASH RC COVID-19 Registry for Hematology
    Meeting Abstract

    Hicks, L. K.; Redd, R. A.; Anderson, K. C.; Desai, P.; Dolan, B.; Goldberg, A. D.; Narendra, V.; Neuberg, D. S.; Radhakrishnan, V.; Sehn, L. H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of secondary acute myeloid leukemia with mixed phenotype
    Meeting Abstract

    Galera, P.; Chan, A.; Derkach, A.; Liu, Y.; Baik, J.; Famulare, C.; Sigler, A.; Arcila, M. E.; Mata, D. A.; Dogan, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Patients with AML who achieve long term complete remission do not have a normal life expectancy when compared to the general population. Analysis of 3,012 patients enrolled on 9 consecutive ECOG-ACRIN trials
    Meeting Abstract

    Ganzel, C.; Roopcharan, K.; Sun, Z.; Rowe, J. M.; Fernandez, H. F.; Paietta, E. M.; Luger, S. M.; Lazarus, H. M.; Cripe, L. D.; Douer, D.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical predictors of outcome in adult patients with acute leukemias and myelodysplastic syndrome and COVID-19 Infection: Report from the American Society of Hematology Research Collaborative (ASH RC) data hub
    Meeting Abstract

    Desai, P.; Goldberg, A. D.; Anderson, K. C.; Narendra, V.; Neuberg, D. S.; Radhakrishnan, V.; Redd, R. A.; Roboz, G. J.; Sehn, L. H.; Sekeres, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib
    Journal Article

    Wang, X. V.; Hanson, C. A.; Tschumper, R. C.; Lesnick, C. E.; Braggio, E.; Paietta, E. M.; O'Brien, S.; Barrientos, J. C.; Leis, J. F.; Zhang, C. C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Does the conventional cytogenetic risk profile still matter for prediction of venetoclax based treatment outcomes in AML?
    Editorial

    Bewersdorf, J. P.; Stone, R. M.; Tallman, M. S.; Stahl, M.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Hypomethylating agents and FLT3 inhibitors as maintenance treatment for acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation - A systematic review and meta-analysis
    Review

    Bewersdorf, J. P.; Allen, C.; Mirza, A. S.; Grimshaw, A. A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Cho, C.; Tallman, M. S.; Zeidan, A. M.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • CNS involvement in AML at diagnosis is rare and does not affect response or survival: Data from 11 ECOG-ACRIN trials
    Journal Article

    Ganzel, C.; Lee, J. W.; Fernandez, H. F.; Paietta, E. M.; Luger, S. M.; Lazarus, H. M.; Cripe, L. D.; Douer, D.; Wiernik, P. H.; Rowe, J. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis
    Meeting Abstract

    Bewersdorf, J. P.; Sheth, A.; Vetsa, S.; Grimshaw, A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Tamari, R.; Tallman, M. S.; Rampal, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save